VERTESS Closes 5 Deals in Q3 2023 with Combined Value of $75M

FORT WORTH, Texas, Oct. 25, 2023 /PRNewswire/ -- VERTESS (www.vertess.com), a leading healthcare mergers and acquisitions (M&A) advisory firm, today announced the closing of five major healthcare transactions in Q3 2023 with a combined total transaction value of $75,000,000. The five transactions were in various healthcare verticals. The headwinds faced earlier in the year due to global and domestic economic pressures are clearing and signs for a profitable Q4 and 2024 are strong. 

Bradley Smith, the Managing Director for one of the sellers stated, "At the end of 2022 and early 2023, we saw a sharp decline in the pace of M&A activity. We continued to push forward and remain patient. We are pleased for our clients that our perseverance with buyers resulted in several successes."

The healthcare verticals for the five closed transactions included Pediatric-focused Home Medical Equipment and Service Providers, Home Health Care Services, Custom Rehab and Durable Medical Equipment, as well as Retail Pharmacy. Over half of the VERTESS Managing Directors successfully closed deals in Q3.

"We are encouraged by the uptick in deal activity at the end of 2023," commented VERTESS Managing Partner Vaughne Glennie. "Although the dry powder remained available for many buyers, there was clearly some risk avoidance starting in mid-2022.  As we continue to launch new deals this fall, the heightened response we've received from buyers clearly shows a trend toward a very active 2024 in healthcare M&A." She added, "Our Managing Directors are always available to talk to healthcare business owners about their future goals and to be a resource for any exit planning."

For more information, please contact Vaughne Glennie at [email protected] or +1.202.302.1621.

About VERTESS

VERTESS is an international healthcare-focused Mergers & Acquisitions (M&A) advisory firm with expertise spanning diverse healthcare and human service verticals, ranging from behavioral health and intellectual/developmental disabilities to DME, pharmacies, home care/hospice, urgent care, life sciences, and other specialized services and products. Each VERTESS Managing Director has had executive experience in either launching or managing and ultimately successfully exiting a healthcare company.

VERTESS is headquartered in Dallas/Fort Worth, Texas, with additional offices in Arizona, California, Colorado, Florida, Massachusetts, Pennsylvania, New Jersey, and Texas. For more information, visit www.vertess.com.

For further information about VERTESS please contact Vaughne Glennie at [email protected].

SOURCE VERTESS